Cargando…

[5]-Helistatins: Tubulin-Binding Helicenes with Antimitotic Activity

[Image: see text] Helicenes are high interest synthetic targets with unique conjugated helical structures that have found important technological applications. Despite this interest, helicenes have had limited impact in chemical biology. Herein, we disclose a first-in-class antimitotic helicene, hel...

Descripción completa

Detalles Bibliográficos
Autores principales: Rushworth, James L., Thawani, Aditya R., Fajardo-Ruiz, Elena, Meiring, Joyce C. M., Heise, Constanze, White, Andrew J. P., Akhmanova, Anna, Brandt, Jochen R., Thorn-Seshold, Oliver, Fuchter, Matthew J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2022
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9709948/
https://www.ncbi.nlm.nih.gov/pubmed/36465552
http://dx.doi.org/10.1021/jacsau.2c00435
_version_ 1784841270794911744
author Rushworth, James L.
Thawani, Aditya R.
Fajardo-Ruiz, Elena
Meiring, Joyce C. M.
Heise, Constanze
White, Andrew J. P.
Akhmanova, Anna
Brandt, Jochen R.
Thorn-Seshold, Oliver
Fuchter, Matthew J.
author_facet Rushworth, James L.
Thawani, Aditya R.
Fajardo-Ruiz, Elena
Meiring, Joyce C. M.
Heise, Constanze
White, Andrew J. P.
Akhmanova, Anna
Brandt, Jochen R.
Thorn-Seshold, Oliver
Fuchter, Matthew J.
author_sort Rushworth, James L.
collection PubMed
description [Image: see text] Helicenes are high interest synthetic targets with unique conjugated helical structures that have found important technological applications. Despite this interest, helicenes have had limited impact in chemical biology. Herein, we disclose a first-in-class antimitotic helicene, helistatin 1 (HA-1), where the helicene scaffold acts as a structural mimic of colchicine, a known antimitotic drug. The synthesis proceeds via sequential Pd-catalyzed coupling reactions and a π-Lewis acid cycloisomerization mediated by PtCl(2). HA-1 was found to block microtubule polymerization in both cell-free and live cell assays. Not only does this demonstrate the feasibility of using helicenes as bioactive scaffolds against protein targets, but also suggests wider potential for the use of helicenes as isosteres of biaryls or cis-stilbenes—themselves common drug and natural product scaffolds. Overall, this study further supports future opportunities for helicenes for a range of chemical biological applications.
format Online
Article
Text
id pubmed-9709948
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher American Chemical Society
record_format MEDLINE/PubMed
spelling pubmed-97099482022-12-01 [5]-Helistatins: Tubulin-Binding Helicenes with Antimitotic Activity Rushworth, James L. Thawani, Aditya R. Fajardo-Ruiz, Elena Meiring, Joyce C. M. Heise, Constanze White, Andrew J. P. Akhmanova, Anna Brandt, Jochen R. Thorn-Seshold, Oliver Fuchter, Matthew J. JACS Au [Image: see text] Helicenes are high interest synthetic targets with unique conjugated helical structures that have found important technological applications. Despite this interest, helicenes have had limited impact in chemical biology. Herein, we disclose a first-in-class antimitotic helicene, helistatin 1 (HA-1), where the helicene scaffold acts as a structural mimic of colchicine, a known antimitotic drug. The synthesis proceeds via sequential Pd-catalyzed coupling reactions and a π-Lewis acid cycloisomerization mediated by PtCl(2). HA-1 was found to block microtubule polymerization in both cell-free and live cell assays. Not only does this demonstrate the feasibility of using helicenes as bioactive scaffolds against protein targets, but also suggests wider potential for the use of helicenes as isosteres of biaryls or cis-stilbenes—themselves common drug and natural product scaffolds. Overall, this study further supports future opportunities for helicenes for a range of chemical biological applications. American Chemical Society 2022-10-19 /pmc/articles/PMC9709948/ /pubmed/36465552 http://dx.doi.org/10.1021/jacsau.2c00435 Text en © 2022 The Authors. Published by American Chemical Society https://creativecommons.org/licenses/by/4.0/Permits the broadest form of re-use including for commercial purposes, provided that author attribution and integrity are maintained (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Rushworth, James L.
Thawani, Aditya R.
Fajardo-Ruiz, Elena
Meiring, Joyce C. M.
Heise, Constanze
White, Andrew J. P.
Akhmanova, Anna
Brandt, Jochen R.
Thorn-Seshold, Oliver
Fuchter, Matthew J.
[5]-Helistatins: Tubulin-Binding Helicenes with Antimitotic Activity
title [5]-Helistatins: Tubulin-Binding Helicenes with Antimitotic Activity
title_full [5]-Helistatins: Tubulin-Binding Helicenes with Antimitotic Activity
title_fullStr [5]-Helistatins: Tubulin-Binding Helicenes with Antimitotic Activity
title_full_unstemmed [5]-Helistatins: Tubulin-Binding Helicenes with Antimitotic Activity
title_short [5]-Helistatins: Tubulin-Binding Helicenes with Antimitotic Activity
title_sort [5]-helistatins: tubulin-binding helicenes with antimitotic activity
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9709948/
https://www.ncbi.nlm.nih.gov/pubmed/36465552
http://dx.doi.org/10.1021/jacsau.2c00435
work_keys_str_mv AT rushworthjamesl 5helistatinstubulinbindingheliceneswithantimitoticactivity
AT thawaniadityar 5helistatinstubulinbindingheliceneswithantimitoticactivity
AT fajardoruizelena 5helistatinstubulinbindingheliceneswithantimitoticactivity
AT meiringjoycecm 5helistatinstubulinbindingheliceneswithantimitoticactivity
AT heiseconstanze 5helistatinstubulinbindingheliceneswithantimitoticactivity
AT whiteandrewjp 5helistatinstubulinbindingheliceneswithantimitoticactivity
AT akhmanovaanna 5helistatinstubulinbindingheliceneswithantimitoticactivity
AT brandtjochenr 5helistatinstubulinbindingheliceneswithantimitoticactivity
AT thornsesholdoliver 5helistatinstubulinbindingheliceneswithantimitoticactivity
AT fuchtermatthewj 5helistatinstubulinbindingheliceneswithantimitoticactivity